QR kód

Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial

Abstract Background This study aimed to assess the efficacy and safety of transarterial chemoembolization (TACE) in combination with apatinib (TACE-apatinib) for patients with unresectable hepatocellular carcinoma (HCC). Methods This study was a multicenter, randomized, open-label, prospective, phas...

Celý popis

Uloženo v:
Hlavní autoři: Xue-Feng Kan, Bin Liang, Xiao-Lin Zhang, Lei Yu, Yao-Chang Luo, Shi Zhou, Rui-Bao Liu, Guo-Hui Xu, Hai-Liang Li, Zheng-Yin Liao, Hua Xiang, Wei Lu, Lin-Feng Xu, Yi-Long Ma, Xiang-Wen Xia, Kun Qian, Xiang-Jun Dong, Fu Xiong, Song-Lin Song, Chang Zhao, Ming Huang, Chuan-Sheng Zheng
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2025-05-01
Edice:BMC Medicine
Témata:
Transarterial chemoembolization
Apatinib
Hepatocellular carcinoma
Progression free survival
On-line přístup:https://doi.org/10.1186/s12916-025-04159-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky